USPTO 2015–2025 USPTO PatentsView US Corporation

ChemoMouthPiece, LLC

USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Chemomouthpiece ranks #31,185 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.

#31,185
of 49,997 US assignees by volume
Top 27%
by Innovation Score (43.8/100)
15.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R31185 · US Corporation #31,185 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 8 grants
  • MID-PACK #31,185/49,997
  • PHOTO-FINISH Charm Industrial
  • CPC-NARROW A61F · 4 areas
  • INNOV-PAR 43.8/100
  • CLAIMS-RICH 15.3 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2024 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Charm Industrial, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Chemomouthpiece

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Chemomouthpiece's Innovation Score is 43.8/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Chemomouthpiece's grants concentrate

ChemoMouthPiece, LLC is a focused PatentsView assignee: 4 CPC subclasses with 50% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2020. By volume, Chemomouthpiece sits between Charm Industrial, Inc. and China Academy of Art.

Chemomouthpiece's three-year grant acceleration

ChemoMouthPiece, LLC shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at ChemoMouthPiece's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows ChemoMouthPiece holds 8 patents at rank #31,276, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near ChemoMouthPiece

By rank, the assignees closest to #31,276 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in ChemoMouthPiece's primary technology class.

Chemomouthpiece's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 20202021202220232024 1
USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
ChemoMouthPiece, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 12.5%
2021 1 12.5%
2022 4 50.0%
2023 1 12.5%
2024 1 12.5%

Where it ranks

Overall rank by patents

#31,185

of 49,997 tracked assignees

Innovation Score

43.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

ChemoMouthPiece, LLC's patent record in context - here's where to go next.

  • ChemoMouthPiece, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 50% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #31,185 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare ChemoMouthPiece, LLC against Charm Industrial, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.